Skip to main content

Australia s Peter Mac, NICTA to Collaborate on Array Data Analysis

NEW YORK, Dec. 21 (GenomeWeb News) - Australia's Peter MacCallum Cancer Center and National Information and Communications Technology Agency are working together to develop new microarray data analysis software, NICTA said last week.

 

Researchers from the Melbourne, Australia-based cancer center will work with NICTA to sift microarray data for patterns of gene activity distinctive to different cancers.

 

The partners will use NICTA's Statistical Machine Learning research program to develop software to diagnose cancers, and select therapies appropriate to each patient's personal prognosis.

 

Adam Kowalczyk, senior researcher in NICTA's SML research program, said in a statement that the initial effort will concentrate on developing a method for discerning biologically meaningful information from microarray profiles of tissue, with a focus on cancer diagnosis and treatment. "Once we have established this methodology we will move to the development of practical algorithms and software tools for operation testing, demonstration, and operational implementation," he said.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.